(S1 (S (S (NP (NN PUMA)) (VP (VBZ suppresses) (NP (NP (JJ intestinal) (NN tumorigenesis)) (PP (IN in) (NP (NNS mice)))))) (. .)))
(S1 (S (S (NP (JJ Defective) (NN apoptosis)) (VP (VBZ contributes) (PP (TO to) (NP (NN tumorigenesis))) (, ,) (SBAR (IN although) (S (NP (DT the) (JJ critical) (JJ molecular) (NNS targets)) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (ADVP (RB fully)) (VP (VBN characterized)))))))))) (. .)))
(S1 (S (S (NP (NP (NN PUMA)) (, ,) (NP (NP (DT a) (JJ BH3-only) (NN protein)) (ADJP (JJ essential) (PP (IN for) (NP (JJ p53-dependent) (NN apoptosis))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB suppress) (NP (NN lymphomagenesis))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN PUMA))) (PP (IN in) (NP (JJ intestinal) (NN tumorigenesis)))) (S (VP (VBG using) (NP (CD two) (NN animal) (NNS models)))))) (. .)))
(S1 (S (PP (IN In) (NP (DT the) (NP (NP (NN azoxymethane)) (PRN (-LRB- -LRB-) (NP (NN AOM)) (-RRB- -RRB-))) (NN /dextran) (NN sulfate) (NN sodium) (NN salt) (NN model))) (, ,) (NP (NN PUMA) (NN deficiency)) (VP (VP (VBD increased) (NP (NP (DT the) (NP (NN multiplicity)) (CC and) (NP (NN size))) (PP (IN of) (NP (NN colon) (NNS tumors))))) (CC but) (VP (VBD reduced) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN beta-catenin) (NN hotspot) (NNS mutations)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NN PUMA)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (ADJP (RB significantly) (JJ elevated)) (NN incidence)) (PP (IN of) (NP (NP (NN precursor) (NNS lesions)) (VP (VBN induced) (PP (IN by) (NP (NN AOM)))))))))) (. .)))
(S1 (S (S (NP (NN AOM)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB induce) (NP (NP (JJ p53-dependent) (NN PUMA) (NN expression)) (CC and) (NP (JJ PUMA-dependent) (NN apoptosis))) (PP (IN in) (NP (NP (DT the) (JJ colonic) (NNS crypts)) (CC and) (NP (NN stem) (NN cell) (NN compartment)))))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN PUMA) (NN deficiency)) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (JJ spontaneous) (NNS macroadenomas)) (CC and) (NP (NNS microadenomas))))) (PP (IN in) (NP (NP (DT the) (NP (JJ distal) (JJ small) (NN intestine)) (CC and) (NP (NN colon))) (PP (IN of) (NP (JJ APC-LRB-Min/+-RRB-) (NNS mice))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP show) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN of) (NP (JJ PUMA-mediated) (NN apoptosis))) (PP (IN in) (S (VP (VBG suppressing) (NP (NP (JJ intestinal) (NN tumorigenesis)) (PP (IN in) (NP (NNS mice)))))))))) (. .)))
